Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bosq

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocolsS Bodis, M Henry-Amar, J Bosq, et al.
Radiology|August 1, 1997
Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patientsN Lassau, J Leclère, A Auperin, et al.
Cancer Genetics and Cytogenetics|May 14, 2003
Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse modelR M'kacher, F Farace, A Bennaceur-Griscelli, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2001
A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatmentT Girinsky, D Guillot-Vals, S Koscielny, et al.
Blood|March 21, 1998
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localizationB Arnulf, C Copie-Bergman, M H Delfau-Larue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2009
JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcomeR M'kacher, L Andreoletti, S Flamant, et al.
Bone Marrow Transplantation|June 19, 1998
VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's diseaseV Ribrag, F Nasr, J H Bouhris, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1996
Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeksJ Bourhis, R Dendale, C Hill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter studyF Grange, M W Bekkenk, J Wechsler, et al.
Leukemia & Lymphoma|August 1, 1997
Mantle cell lymphomas: characteristics, natural history and prognostic factors of 45 casesD Decaudin, J Bosq, J N Munck, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocolsS Bodis, M Henry-Amar, J Bosq, et al.
Radiology|August 1, 1997
Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patientsN Lassau, J Leclère, A Auperin, et al.
Cancer Genetics and Cytogenetics|May 14, 2003
Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse modelR M'kacher, F Farace, A Bennaceur-Griscelli, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2001
A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatmentT Girinsky, D Guillot-Vals, S Koscielny, et al.
Blood|March 21, 1998
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localizationB Arnulf, C Copie-Bergman, M H Delfau-Larue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2009
JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcomeR M'kacher, L Andreoletti, S Flamant, et al.
Bone Marrow Transplantation|June 19, 1998
VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's diseaseV Ribrag, F Nasr, J H Bouhris, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1996
Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeksJ Bourhis, R Dendale, C Hill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter studyF Grange, M W Bekkenk, J Wechsler, et al.
Leukemia & Lymphoma|August 1, 1997
Mantle cell lymphomas: characteristics, natural history and prognostic factors of 45 casesD Decaudin, J Bosq, J N Munck, et al.
Pageof 10